Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. | Front Endocrinol (Lausanne) | 2022 | 35957812 | PubTator, text mining | PubMed |
| Low-Dose Radiation Affects Cardiovascular Disease Risk in Human Aortic Endothelial Cells by Altering Gene Expression under Normal and Diabetic Conditions. | Int J Mol Sci | 2022 | 35955709 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems. | Clin Exp Metastasis | 2022 | 35939247 | PubTator, text mining | PubMed |
| Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer. | Front Mol Biosci | 2022 | 35903153 | PubTator, text mining | PubMed |
| The Role of SETBP1 in Gastric Cancer: Friend or Foe. | Front Oncol | 2022 | 35898891 | PubTator, text mining | PubMed |
| Role of pH in Regulating Cancer Pyrimidine Synthesis. | J Xenobiot | 2022 | 35893264 | PubTator, text mining | PubMed |
| Blood Biomarkers for Triaging Patients for Suspected Stroke: Every Minute Counts. | J Clin Med | 2022 | 35888011 | PubTator, text mining | PubMed |
| Conditioned Medium of Human Pluripotent Stem Cell-Derived Neural Precursor Cells Exerts Neurorestorative Effects against Ischemic Stroke Model. | Int J Mol Sci | 2022 | 35887140 | PubTator, text mining | PubMed |
| Use of Publication Dynamics to Distinguish Cancer Genes and Bystander Genes. | Genes (Basel) | 2022 | 35885888 | PubTator, text mining | PubMed |
| Profiling the Site of Protein CoAlation and Coenzyme A Stabilization Interactions. | Antioxidants (Basel) | 2022 | 35883853 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. | Cell Death Discov | 2022 | 35879279 | PubTator, text mining | PubMed |
| Insight Into the Metabolic Adaptations of Electrically Pulse-Stimulated Human Myotubes Using Global Analysis of the Transcriptome and Proteome. | Front Physiol | 2022 | 35874526 | PubTator, text mining | PubMed |
| Integrated computational approaches to screen gene expression data to determine key genes and therapeutic targets for type-2 diabetes mellitus. | Saudi J Biol Sci | 2022 | 35844380 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies. | Front Oncol | 2022 | 35814444 | PubTator, text mining | PubMed |
| Metabolic Disruption by Naturally Occurring Mycotoxins in Circulation: A Focus on Vascular and Bone Homeostasis Dysfunction. | Front Nutr | 2022 | 35811967 | PubTator, text mining | PubMed |
| Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives. | Int J Mol Sci | 2022 | 35806271 | PubTator, text mining | PubMed |
| Plasmid-to-plasmid Southern blot analysis validates the presence of nucleotide binding site (nbs) sequences in cloned plasmids. | Biochem Mol Biol Educ | 2022 | 35791664 | PubTator, text mining | PubMed |
| G4-quadruplex-binding proteins: review and insights into selectivity. | Biophys Rev | 2022 | 35791380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=18